Cerity Partners’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.63M | Buy |
140,772
+114,407
| +434% | +$1.32M | ﹤0.01% | 1305 |
|
|
2025
Q1 | $230K | Sell |
26,365
-3,663
| -12% | -$32K | ﹤0.01% | 2143 |
|
|
2024
Q4 | $451K | Sell |
30,028
-6,339
| -17% | -$95.3K | ﹤0.01% | 1822 |
|
|
2024
Q3 | $821K | Buy |
36,367
+10,815
| +42% | +$244K | ﹤0.01% | 1501 |
|
|
2024
Q2 | $497K | Buy |
25,552
+555
| +2% | +$10.8K | ﹤0.01% | 1546 |
|
|
2024
Q1 | $938K | Buy |
24,997
+10,500
| +72% | +$394K | ﹤0.01% | 1306 |
|
|
2023
Q4 | $811K | Buy |
+14,497
| New | +$811K | ﹤0.01% | 1057 |
|
|
2023
Q2 | – | Sell |
-14,183
| Closed | -$790K | – | 1946 |
|
|
2023
Q1 | $790K | Sell |
14,183
-869
| -6% | -$48.4K | ﹤0.01% | 1081 |
|
|
2022
Q4 | $548K | Sell |
15,052
-133
| -0.9% | -$4.85K | ﹤0.01% | 900 |
|
|
2022
Q3 | $432K | Sell |
15,185
-1,636
| -10% | -$46.5K | 0.01% | 768 |
|
|
2022
Q2 | $761K | Buy |
16,821
+338
| +2% | +$15.3K | 0.01% | 614 |
|
|
2022
Q1 | $1.25M | Buy |
16,483
+14,491
| +727% | +$1.1M | 0.02% | 408 |
|
|
2021
Q4 | $296K | Buy |
1,992
+416
| +26% | +$61.8K | ﹤0.01% | 773 |
|
|
2021
Q3 | $229K | Buy |
1,576
+127
| +9% | +$18.5K | 0.01% | 622 |
|
|
2021
Q2 | $284K | Buy |
1,449
+202
| +16% | +$39.6K | 0.01% | 598 |
|
|
2021
Q1 | $226K | Buy |
+1,247
| New | +$226K | 0.01% | 627 |
|